- Home
- CGON vs LBRT Comparison
CGON vs LBRT Comparison
Compare CGON & LBRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGON
- LBRT
- Stock Information
- Founded
- CGON 2010
- LBRT 2011
- Country
- CGON United States
- LBRT United States
- Employees
- CGON N/A
- LBRT N/A
- Industry
- CGON
- LBRT Oilfield Services/Equipment
- Sector
- CGON
- LBRT Energy
- Exchange
- CGON NYSE
- LBRT Nasdaq
- Market Cap
- CGON 2.1B
- LBRT 1.9B
- IPO Year
- CGON 2024
- LBRT 2018
- Fundamental
- Price
- CGON $25.55
- LBRT $12.99
- Analyst Decision
- CGON Strong Buy
- LBRT Buy
- Analyst Count
- CGON 10
- LBRT 11
- Target Price
- CGON $64.44
- LBRT $17.50
- AVG Volume (30 Days)
- CGON 784.3K
- LBRT 2.9M
- Earning Date
- CGON 08-07-2025
- LBRT 07-16-2025
- Dividend Yield
- CGON N/A
- LBRT 2.46%
- EPS Growth
- CGON N/A
- LBRT N/A
- EPS
- CGON N/A
- LBRT 1.51
- Revenue
- CGON $662,000.00
- LBRT $4,219,497,000.00
- Revenue This Year
- CGON N/A
- LBRT N/A
- Revenue Next Year
- CGON $14,719.70
- LBRT $2.83
- P/E Ratio
- CGON N/A
- LBRT $8.59
- Revenue Growth
- CGON 224.51
- LBRT N/A
- 52 Week Low
- CGON $14.80
- LBRT $9.50
- 52 Week High
- CGON $40.47
- LBRT $24.43
- Technical
- Relative Strength Index (RSI)
- CGON 48.31
- LBRT 54.46
- Support Level
- CGON $25.02
- LBRT $11.83
- Resistance Level
- CGON $26.97
- LBRT $13.79
- Average True Range (ATR)
- CGON 1.14
- LBRT 0.59
- MACD
- CGON -0.18
- LBRT 0.10
- Stochastic Oscillator
- CGON 17.79
- LBRT 64.29
About CGON CG ONCOLOGY INC
CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. The company's lead candidate, cretostimogene grenadenorepvec, is a targeted oncolytic intravesically delivered immunotherapy agent that is in two phase three trials (one high-risk BCG unresponsive NMIBC trial and one intermediate-risk NMIBC trial) and a phase two clinical study with a checkpoint inhibitor for high-risk BCG unresponsive NMIBC disease.
About LBRT Liberty Energy Inc.
Liberty Energy Inc is a integrated energy services and technology company focused on providing hydraulic fracturing services and related technologies to onshore oil and natural gas exploration and production (E&P) companies. The Company offers customers with hydraulic fracturing services, together with complementary services including wireline services, proppant delivery solutions, field gas processing and treating, compressed natural gas (CNG) delivery, data analytics, related goods (including sand mine operations), and technologies to facilitate lower emission completions, thereby helping customers reduce emissions profile. The company provides services across USA and Canada.